In April 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the bodybuilder Nirmal Kumar Shetter after his sample tested positive for the prohibited substances Canrenone, Drostanolone, Mephentermine, Phentermine and Stanozolol.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Panel finds that the presence of prohibited substances has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. The Panel deems that the Athlete failed to demonstrate that the violation was not intentional.
Therefore the Panel decides on 12 September 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 April 2023.